Trulieve Posts Q1 Revenues Of $215.1 Million, Net Income

Trulieve Cannabis (CSE: TRUL) this morning reported its second quarter financial results, healthily beating analyst consensus estimates. The company reported quarterly revenues of $215.1 million, while generating net income of $40.9 million.

Revenues for the quarter were up from $193.8 million, an 11% improvement on a quarter over quarter basis. Gross profit meanwhile came in at $144.5 million, or 67%, a decline of three percentage points from the prior quarter.

Operating expenses meanwhile amounted to $61.5 million, enabling the company to post a net income of $40.9 million. Adjusted EBITDA meanwhile amounted to $94.9 million, a 4% increase from the first quarters $90.8 million recorded, and a beat for analyst consensus estimates.

Full financial results have yet to be released by the company.

The company also indicated this morning that its operations are now running in both Massachusetts and West Virginia, while the company also recently won a class 1 production license in the state of Georgia.

The company last night also saw Harvest Health (CSE: HARV) shareholders approve of the proposed merger between the two firms.

Trulieve Cannabis last traded at $40.04 on the CSE.


Information for this briefing was found via Sedar and Trulieve Cannabis Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Trulieve: Analysts Raise Price Targets Following Q4 Results

Yesterday, Trulieve Cannabis (CSE: TRUL) announced their fourth quarter and year-end financial for 2020. The...

Saturday, March 27, 2021, 02:45:00 PM

Trulieve Sees Canaccord Maintain $35 Price Target Days Before Share Unlock

Trulieve Cannabis (CSE: TRUL) this morning saw Canaccord Genuity reaffirm its speculative buy rating on...

Wednesday, May 13, 2020, 11:20:52 AM

Trulieve: Canaccord Reiterates $97 Price Target After Virtual Roadshow

Over the last week, Trulieve Cannabis (CSE: TRUL) went on a virtual roadshow mainly focused...

Tuesday, July 6, 2021, 04:04:00 PM

Trulieve Cannabis Closes Acquisition Of Harvest Health

Trulieve Cannabis (CSE: TRUL) has finally completed the acquisition of Harvest Health (CSE: HARV). It...

Friday, October 1, 2021, 07:43:45 AM

Trulieve: Analysts Expect US$221 Million In Q3 Revenues

Trulieve (CSE: TRUL) announced that they will be reporting their third quarter financials before the...

Sunday, November 14, 2021, 04:17:00 PM